Chase Leavitt Buys 2,000 Shares of Mobia Medical (NASDAQ:MOBI) Stock

Mobia Medical, Inc. (NASDAQ:MOBI) insider Chase Leavitt acquired 2,000 shares of the stock in a transaction on Friday, September 11th. The stock was bought at an average price of $10.30 per share, with a total value of $20,600.00. Following the transaction, the insider directly owned 5,000 shares in the company, valued at approximately $51,500. This represents a 66.67% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Mobia Medical Price Performance

Shares of MOBI stock traded up $0.74 during trading hours on Tuesday, reaching $10.77. 316,997 shares of the company were exchanged, compared to its average volume of 154,045. Mobia Medical, Inc. has a fifty-two week low of $9.85 and a fifty-two week high of $15.29. The business has a fifty day moving average price of $11.51. The firm has a market cap of $358.53 million and a P/E ratio of -0.53. The company has a debt-to-equity ratio of 0.04, a quick ratio of 12.80 and a current ratio of 13.28.

Mobia Medical (NASDAQ:MOBI) last issued its quarterly earnings results on Tuesday, August 11th. The company reported ($1.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.83) by ($0.27). The company had revenue of $13.51 million for the quarter. The firm’s revenue for the quarter was up 102.4% compared to the same quarter last year. On average, research analysts anticipate that Mobia Medical, Inc. will post -2.63 earnings per share for the current year.

Institutional Trading of Mobia Medical

An institutional investor recently bought a new position in Mobia Medical stock. Readystate Asset Management LP acquired a new position in shares of Mobia Medical, Inc. (NASDAQ:MOBI) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 10,000 shares of the company’s stock, valued at approximately $134,000.

Analysts Set New Price Targets

Several equities research analysts have recently commented on MOBI shares. The Goldman Sachs Group started coverage on Mobia Medical in a research note on Tuesday, June 2nd. They issued a “buy” rating and a $31.00 target price for the company. Zacks Research upgraded Mobia Medical to a “hold” rating in a research report on Wednesday, June 3rd. JPMorgan Chase & Co. boosted their price objective on Mobia Medical from $15.00 to $17.00 and gave the stock an “overweight” rating in a report on Wednesday, August 12th. Bank of America initiated coverage on shares of Mobia Medical in a research report on Tuesday, June 2nd. They set a “buy” rating and a $16.00 target price on the stock. Finally, Weiss Ratings initiated coverage on shares of Mobia Medical in a research note on Wednesday, August 12th. They issued a “sell (e-)” rating on the stock. Five equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $20.75.

Mobia Medical Company Profile

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.